Literature DB >> 8055022

Family and out-of-pocket costs for women with breast cancer.

B A Given, C W Given, M Stommel.   

Abstract

Other than loss of income to family members, little attention has been given to costs incurred by women with breast cancer and their families. Informal costs, such as the family labor for patient care and nonreimbursed out-of-pocket expenditures to care for the patient with breast cancer, need to be considered. Informal costs of women who survived for at least 3 months after the observation are compared with informal costs of a group of patients who died during the subsequent 3 months. Data for this longitudinal descriptive study were obtained from a convenience sample of 62 women with new or recurrent breast cancer. Data were collected at intake and at 3-month intervals across the 6-month observation. Data are presented for the out-of-pocket costs, primary family care-giver and "other" family labor costs, and total costs. Considering all costs, the 3-month average was $2,720 (SD, $3314) for the survivors and $7905 (SD, $5448) for the decedents. Regressions of costs on predictors were performed; survivors' status and patient dependencies in activities of daily living were the only significant predictors. Family care costs need to be considered along with the formal and direct reimbursable medical costs as an essential component of breast cancer care cost.

Entities:  

Mesh:

Year:  1994        PMID: 8055022

Source DB:  PubMed          Journal:  Cancer Pract        ISSN: 1065-4704


  27 in total

1.  Gender, age and surgery as a treatment modality leads to higher distress in patients with cancer.

Authors:  Bejoy C Thomas; V NandaMohan; Madhvan K Nair; Manoj Pandey
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

2.  Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI).

Authors:  Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees
Journal:  Breast Cancer Res Treat       Date:  2010-10-26       Impact factor: 4.872

3.  Accurate Measurement of Financial Toxicity Is a Prerequisite to Finding a Remedy.

Authors:  Adam Martin; Peter S Hall
Journal:  Breast Care (Basel)       Date:  2017-04-26       Impact factor: 2.860

4.  Role recognition and changes to self-identity in family caregivers of people with advanced cancer: a qualitative study.

Authors:  Anna Ugalde; Meinir Krishnasamy; Penelope Schofield
Journal:  Support Care Cancer       Date:  2011-05-25       Impact factor: 3.603

Review 5.  Breast cancer control among the underserved--an overview.

Authors:  N Breen; L G Kessler; M L Brown
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Does economic burden influence quality of life in breast cancer survivors?

Authors:  Karen Meneses; Andres Azuero; Lauren Hassey; Patrick McNees; Maria Pisu
Journal:  Gynecol Oncol       Date:  2011-11-29       Impact factor: 5.482

Review 7.  The out of pocket cost of breast cancer survivors: a review.

Authors:  Maria Pisu; Andres Azuero; Patrick McNees; Jeffrey Burkhardt; Rachel Benz; Karen Meneses
Journal:  J Cancer Surviv       Date:  2010-04-17       Impact factor: 4.442

Review 8.  The costs of treating breast cancer in the US: a synthesis of published evidence.

Authors:  Jonathan D Campbell; Scott D Ramsey
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Work, gender, and stress in family cancer caregiving.

Authors:  Joseph E Gaugler; William C Given; Jeanette Linder; Ritesh Kataria; Galina Tucker; William F Regine
Journal:  Support Care Cancer       Date:  2007-09-21       Impact factor: 3.603

10.  Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers.

Authors:  Sophie Lauzier; Elizabeth Maunsell; Mélanie Drolet; Douglas Coyle; Nicole Hébert-Croteau
Journal:  Qual Life Res       Date:  2010-01-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.